Shares of ImmunoGen, Inc. (NASDAQ:IMGN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nine brokerages that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month […]
ImmunoGen (NASDAQ:IMGN) Shares Gap Down After Insider Selling themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
ImmunoGen, Inc. (NASDAQ:IMGN – Get Free Report)’s share price gapped down before the market opened on Friday . The stock had previously closed at $15.76, but opened at $15.34. ImmunoGen shares last traded at $15.59, with a volume of 389,121 shares. Analysts Set New Price Targets IMGN has been the subject of a number of […]
Ironwood Investment Management LLC trimmed its stake in shares of ImmunoGen, Inc. (NASDAQ:IMGN – Free Report) by 2.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 193,753 shares of the biotechnology company’s stock after selling 5,080 shares during the quarter. Ironwood […]
Shares of ImmunoGen, Inc. (NASDAQ:IMGN – Get Free Report) gapped up before the market opened on Tuesday after HC Wainwright raised their price target on the stock from $26.00 to $27.00. The stock had previously closed at $15.54, but opened at $15.99. HC Wainwright currently has a buy rating on the stock. ImmunoGen shares last […]